International Business News - CVD http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Ireland-based Icon PLC, which provides outsourced development services to drug and medical device makers, said Tuesday it will manage drug developer Eli Lilly & Co.'s clinical data management business outside the U.S. and Japan. http://www.ibtimes.com/articles/20081118/icon-signs-clinical-data-deal-with-eli-lilly.htm Tue, 18 Nov 2008 07:16:31 EST Tighter spending within the drug development industry and a decline in foreign exchange benefits likely will weaken revenue expectations throughout the outsourced clinical research sector. http://www.ibtimes.com/articles/20081106/sector-snap-research-cos-brace-for-rough-market.htm Thu, 06 Nov 2008 15:26:52 EST Drug development services company Covance Inc. said Wednesday its third-quarter profit rose 15 percent on higher revenue from early- and late-stage development programs. http://www.ibtimes.com/articles/20081022/covance-3rd-quarter-profit-rises-15-percent.htm Wed, 22 Oct 2008 20:19:12 EDT Drug development services company Covance Inc. said Friday it closed a 10-year, $1.6 billion research agreement with drugmaker Eli Lilly & Co. Princeton, N.J.-based Covance will gain $90 million in annual business with Lilly under the agreement, which was initially struck in August. That is along with the $70 million in annual work Covance already did for Lilly. http://www.ibtimes.com/articles/20081003/covance-and-lilly-complete-10-year-research-pact.htm Fri, 03 Oct 2008 17:19:31 EDT Covance Inc. and WuXi Pharmatech announced Monday they are abandoning plans to build a joint venture for preclinical contract research services in China. http://www.ibtimes.com/articles/20080929/covance-wuxi-abandon-china-venture-plans.htm Mon, 29 Sep 2008 08:42:58 EDT Federal antitrust regulators on Tuesday cleared Eli Lilly & Co.'s $50 million sale of a research facility to drug development services provider Covance Inc. http://www.ibtimes.com/articles/20080826/regulators-clear-50m-sale-of-eli-lilly-facility.htm Tue, 26 Aug 2008 11:47:11 EDT Among the sector activity stories for Wednesday, Aug. 6, from AP Financial News: NEW YORK (AP)--Shares of refiners soared Wednesday as crude prices continued their downward march on the New York Mercantile Exchange, helping to ease part of the burden on the recently troubled sector. http://www.ibtimes.com/articles/20080806/sector-roundup-oil-refiners-jewelry-retailers.htm Wed, 06 Aug 2008 17:26:56 EDT Shares of clinical research companies including Kendle International Inc. and Covance Inc. outpaced the broader market Wednesday as continued demand for outsourced drug development services drives profit and deals. http://www.ibtimes.com/articles/20080806/sector-snap-clinical-research-organizations.htm Wed, 06 Aug 2008 14:00:53 EDT INDIANAPOLIS--Drug-development services company Covance Inc. will buy an Indiana research center from Eli Lilly and Co. and enter a 10-year service deal with the drug maker worth $1.6 billion. http://www.ibtimes.com/articles/20080806/covance-buys-eli-lilly-facility-in-10-year-deal.htm Wed, 06 Aug 2008 16:54:12 EDT Shares of Illumina Inc. and Edwards Lifesciences hit new 52-week highs Wednesday, as a Cowen & Co. analyst said a potential increase in the National Institute of Health's fiscal 2009 budget would be a boon for life science tools makers. http://www.ibtimes.com/articles/20080625/sector-wrap-life-sciences.htm Wed, 25 Jun 2008 15:55:52 EDT Among the stock activity stories for Wednesday, June 25, from AP Financial News: NEW YORK (AP)--Shares of WuXi Pharmatech Inc. surged Wednesday after the Chinese drug development services company said it will create a joint venture with its American peer Covance Inc. http://www.ibtimes.com/articles/20080625/movers-roundup-wuxi-pharmatech-pacer.htm Wed, 25 Jun 2008 14:37:11 EDT Shares of WuXi Pharmatech surged Wednesday after the Chinese drug development services company said it will create a joint venture with its American peer Covance Inc. http://www.ibtimes.com/articles/20080625/wuxi-shares-jump-on-deal-with-covance.htm Wed, 25 Jun 2008 12:51:23 EDT Invitrogen Corp.'s planned $6.4 billion buyout of Applera's Applied Biosystems Group shone a spotlight on the wider life sciences product industry Thursday, boosting investor interest and share prices. http://www.ibtimes.com/articles/20080612/sector-snap-invitrogen-deal-lifts-life-sciences.htm Thu, 12 Jun 2008 15:21:14 EDT Wider international expansion, the confluence of pharmacies and drug suppliers, and a more aggressive generic drug industry will be in focus at the Goldman Sachs annual health care conference in California next week. http://www.ibtimes.com/articles/20080606/goldman-opens-annual-health-care-conference-monday.htm Fri, 06 Jun 2008 15:19:39 EDT Kendle International Inc.'s buyout of its peer DecisionLine Clinical Research Corp. and its reaffirmed guidance sparked a mixed reaction from Wall Street Wednesday, but sent shares higher for the second-consecutive day. http://www.ibtimes.com/articles/20080604/kendle-shares-rise-wall-street-mixed-on-outlook.htm Wed, 04 Jun 2008 19:26:45 EDT Outsourcing by big pharma and biotech companies helped fuel a jump in first-quarter profit for most clinical research organizations, and the trend is expected to continue as drug developers farm out more of their needs to cut costs. http://www.ibtimes.com/articles/20080521/market-spotlight-clinical-research-organizations.htm Wed, 21 May 2008 11:20:15 EDT Covance shares are falling as Wall Street was disappointed by Covance's early-stage clinical revenue and contract bookings in the first quarter. The Princeton, N.J., drug development services company reported its quarterly results late Monday. Its profit of 76 cents per share surpassed Wall Street estimates, although its $412.4 million in revenue was less than expected. But Covance Inc. stock lost $3.07, or 3.6 percent, to $83.29 in afternoon trading. http://www.ibtimes.com/articles/20080429/covance-falls-on-1q-early-stage-revenue-and-contracts.htm Tue, 29 Apr 2008 14:56:40 EDT Among the earnings projection stories for Monday, April 28, from AP Financial News: PRINCETON, N.J. (AP) _ Drug development services company Covance Inc. said Monday it expects profit of $3.18 per share in 2008, matching Wall Street expectations. http://www.ibtimes.com/articles/20080428/outlook-roundup-covance-plum-creek-timber.htm Mon, 28 Apr 2008 18:58:21 EDT Among the earnings stories for Monday, April 28, from AP Financial News: HARTFORD, Conn. (AP) _ Hartford Financial Services Group Inc.'s first-quarter earnings dropped 83 percent as investments turned sour, the financial services firm said Monday. http://www.ibtimes.com/articles/20080428/earnings-roundup-hartford-financial-partnerre.htm Mon, 28 Apr 2008 18:54:45 EDT Drug development services company Covance Inc. said Monday it expects profit of $3.18 per share in 2008, matching Wall Street expectations. The company said favorable market conditions and its broad base of large and small drug-development clients will allow it to boost revenue in the low- to mid-teens. http://www.ibtimes.com/articles/20080428/covance-expects-2008-in-line-with-wall-street-forecasts.htm Mon, 28 Apr 2008 17:20:06 EDT